Fact CheckerSign in

NCT05328258Not yet recruitingPhase 3

ProFertil

A phase III Randomized Double-Blinded Placebo-Controlled Study of Use of GnRHa during Chemotherapy for Fertility Protection of Young Women and Teenagers with Cancer - ProFertil

Source: EU CTIS (euclinicaltrials.eu) · Last updated 25 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To estimate the changes in ovarian reserve following chemotherapy for treatment of cancer with or without GnRHa by determination of the Anti-Müllerian Hormone (AMH) at 12 months after end of gonadotoxic treatment (EOT) in women with breast cancer.

Status (registry)
Not yet recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
500 (estimated)
First submitted
14 Oct 2024
Start date
1 Oct 2022
Lead sponsor
Karolinska University Hospital
NCT number
NCT05328258
EU CT number
2024-518977-32-00
EudraCT number
2020-004780-71

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 500
  • 11 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Ongoing treatment with GnRHa at baseline
  • Direct radiation of the gonads previous or planned (total body irradiation allowed)
  • Previous or planned bilateral oophorectomy
  • Pregnancy or breastfeeding at time of start of chemotherapy
  • Uncontrolled hypertension, heart, liver, kidney related or other uncontrolled medical or psychiatric disorders including previous or current diagnosis of anorexia

Other illness

  • Demonstrated premature ovarian failure at time of randomization according to clinical or biochemical data
  • Other malignancy diagnosed within the last five years
  • Known or suspected allergy against triptorelin

Other

  • Mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation
  • Known osteoporosis
  • Known refractory thrombocytopenia in subjects with acute leukemias

Who the study is looking for

  • Signed informed consent
  • Age 14-42 years at cancer diagnosis
  • Female subjects with breast cancer or acute leukemias, lymphomas (Hodgkin and non-Hodgkin) or sarcomas (osteo, soft tissue and Ewing) confirmed by histology and assigned for disease-specific chemotherapy
  • Confirmed menarche
  • ECOG performance status 0-1
  • Adequate bone marrow, renal, hepatic and cardiac functions and absence of other uncontrolled medical or psychiatric disorders

Age in the registry: - to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (11)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sahlgrenska University Hospital-Vaestra Goetalandsregionen
Coordinator of this site? Confirm its status
GoteborgSwedenNot yet recruiting
Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vaestra Goetalandsregionen
Coordinator of this site? Confirm its status
GothenburgSwedenNot yet recruiting
Karolinska University Hospital
Coordinator of this site? Confirm its status
HuddingeSwedenNot yet recruiting
Region Skane Skanes Universitetssjukhus
Coordinator of this site? Confirm its status
LundSwedenNot yet recruiting
Region Skane Skanes Universitetssjukhus
Coordinator of this site? Confirm its status
MalmoSwedenNot yet recruiting
Region Oerebro Laen
Coordinator of this site? Confirm its status
OrebroSwedenNot yet recruiting
Karolinska University Hospital
Coordinator of this site? Confirm its status
SolnaSwedenNot yet recruiting
Soedersjukhuset AB
Coordinator of this site? Confirm its status
StockholmSwedenNot yet recruiting
Capio S:t Goerans Sjukhus AB
Coordinator of this site? Confirm its status
StockholmSwedenNot yet recruiting
Region Vaesterbotten
Coordinator of this site? Confirm its status
UmeaSwedenNot yet recruiting
Uppsala University Hospital
Coordinator of this site? Confirm its status
UppsalaSwedenNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.